Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Sonnet Biotherapeutics Holdings Inc have a median target of 18.50, with a high estimate of 30.00 and a low estimate of 7.00. The median estimate represents a 1,678.85% increase from the last price of 1.04.
High | 2,784.6% | 30.00 |
Med | 1,678.8% | 18.50 |
Low | 573.1% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Dec 12, 2024.
Average growth rate | +56.05% |
Average growth rate | -88.47% |
More ▼
Revenue history & estimates in USD
Average growth rate | -37.16% |
Average growth rate | -46.55% |
More ▼